Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases
Morgan, D.O.; Fisher, R.P.; Espinoza, F.H.; Farrell, A.; Nourse, J.; Chamberlin, H.; Jin, P.
Cancer Journal from Scientific American 4(Suppl 1): S77-S83
1998
ISSN/ISBN: 1081-4442 PMID: 9619275 Document Number: 490308
Document emailed within 1 workday
Related Documents
Peschos, D.; Tsanou, E.; Stefanou, D.; Damala, C.; Vougiouklakis, T.; Mitselou, A.; Agnantis, N.J. 2004: Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins In Vivo 18(6): 719-724González, J. 2000: Phosphorylation in eukaryotic cells. Role of phosphatases and kinases in the biology, pathogenesis and control of intracellular and bloodstream protozoa Revista Medica de Chile 128(10): 1150-1160
Sadoshima, J.; Aoki, H.; Izumo, S. 1997: Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes Circulation Research 80(2): 228-241
Welcker, M.; Lukas, J.; Strauss, M.; Bartek, J. 1998: p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells Cancer Research 58(22): 5053-5056
Tanguay, D.; Pavlovic, S.; Piatelli, M.J.; Bartek, J.; Chiles, T.C. 1999: B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors Journal of Immunology 163(6): 3160-3168
Williamson, E.A.; Burgess, G.S.; Eder, P.; Litz-Jackson, S.; Boswell, H.S. 1997: Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4 Leukemia 11(1): 73-85
Mayol, X.; Garriga, J.; Graña, X. 1995: Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130 Oncogene 11(4): 801-808
Lucas, J.J.; Terada, N.; Szepesi, A.; Gelfand, E.W. 1992: Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells Journal of Immunology 148(6): 1804-1811
Haapajärvi, T.; Kivinen, L.; Pitkänen, K.; Laiho, M. 1995: Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation Oncogene 11(1): 151-159
Ling, Y.H.; el-Naggar, A.K.; Priebe, W.; Perez-Soler, R. 1996: Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells Molecular Pharmacology 49(5): 832-841
Li, H.; Lahti, J.M.; Kidd, V.J. 1996: Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box Oncogene 13(4): 705-712
Dzgoev, S.G.; Ivanova, L.N. 1990: Phosphorylation of proteins in the kidney papillary zone by endogenous cAMP-dependent protein kinases Biokhimiia 55(5): 814-821
Srour, E.F.; Brandt, J.E.; Leemhuis, T.; Ballas, C.B.; Hoffman, R. 1992: Relationship between cytokine-dependent cell cycle progression and MHC class Ii antigen expression by human CD34+ HLA-DR- bone marrow cells Journal of Immunology 148(3): 815-820
Songia, S.; Mortellaro, A.; Taverna, S.; Fornasiero, C.; Scheiber, E.A.; Erba, E.; Colotta, F.; Mantovani, A.; Isetta, A.M.; Golay, J. 1997: Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets Journal of Immunology 158(8): 3987-3995
Tam, S.W.; Theodoras, A.M.; Shay, J.W.; Draetta, G.F.; Pagano, M. 1994: Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression Oncogene 9(9): 2663-2674
Liang, B.; Wang, S.; Yang, X.; Ye, Y.; Yu, Y.; Cui, Z. 2003: Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer Chinese Medical Journal 116(1): 20-23
Zhang, K.; Kumar, R. 1994: Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells Biochemical and Biophysical Research Communications 200(1): 522-528
Pei, G.; Kieffer, B.L.; Lefkowitz, R.J.; Freedman, N.J. 1995: Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C Molecular Pharmacology 48(2): 173-177
Ohta, T.; Okamoto, K.; Isohashi, F.; Shibata, K.; Fukuda, M.; Yamaguchi, S.; Xiong, Y. 1998: T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21 Cancer Research 58(6): 1095-1098
Gong, J.; Traganos, F.; Darzynkiewicz, Z. 1993: Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements Cancer Research 53(21): 5096-5099